Pokud by byla k dispozici vakcína proti covid-19, chtěli byste být očkováni? A jste očkováni proti chřipce a jiným nemocem? Průzkum mezi studenty vysokých škol v době nouzového stavu

Stáhnout PDF English version

Autoři: M. Sněhota ^1,2; J. Vlčková ³; K. Čížková ⁴; E. Klásková ²; H. Kolářová ^1,5; H. Kollárová ³
Působiště autorů: Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic ¹; Center for Telemedicine, Simulation and Clinical Skills, Faculty of Medicine and Dentistry, Palacký University Olomouc, Czech Republic ²; Department of Public Health, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic ³; Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Czech Republic ⁴; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic ⁵
Vyšlo v časopise: Epidemiol. Mikrobiol. Imunol. 70, 2021, č. 3, s. 147-155
Kategorie: Původní práce

Souhrn

Cíl: Dosažení dostatečné proočkovanosti (respektive kolektivní imunity) je považováno za nejslibnější strategii prevence ohnisek nového onemocnění způsobeného koronaviry v budoucnosti. Hlavním cílem této práce bylo porovnat ochotu vysokoškolských studentů nechat se očkovat proti covid-19 s možnostmi očkovat se proti jiným známým chorobám. Dalším cílem bylo posoudit názor studentů na rostoucí trend rodičů odmítajících očkování dětí.

Metody: Studentům byl rozeslán online dotazník obsahující 12 otázek. Dotazník byl distribuován prostřednictvím univerzitních hromadných e-mailů a sociálních médií.

Výsledky: Na náš dotazník odpovědělo 3 133 studentů. Celková návratnost odpovědí univerzity byla 15,9 %. Studenti naší univerzity projevili významně mnohem větší zájem o očkování proti covid-19 než o vakcíny proti jiným nemocem (p < 0,0001). Studenti také prokázali silný proočkovací postoj k očkování dětí.

Závěr: Studie ukázala velmi dobře náhlou změnu postoje studentů vysokých škol k očkování dospělých v době přísných omezujících předpisů. Většina vysokoškolských studentů měla k očkování dětí proočkovací postoj.

Klíčová slova:

očkování – studenti – průzkum – COVID-19

Zdroje

1. Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent), 2005;18(1):21–25.

2. Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Rev Sci Tech, 2007;26(1):29–48.

3. Plotkin S. History of vaccination. Proc Natl Acad Sci U S A, 2014;111(34):12283–12287.

4. Breman JG, Arita, I, Unit SE, World Health Organization. The confirmation and maintenance of smallpox eradication. No. WHO/ SE/80.156. Geneva, Switzerland: World Health Organization, 1980.

5. Chlíbek R. Očkování dospělých. Praha: Mladá fronta; 2018.

6. CDC. Vaccine Information for adults. (available online on 12.05.2021). Available from: https://www.cdc.gov/features/ adultimmunizations/index.html

7. Ozisik L, Tanriover MD, Rigby S, et al. European Federation of Internal Medicine ADVICE Working Group. ADVICE for a healthier life: Adult Vaccination Campaign in Europe. Eur J Intern Med, 2016;33:14–20.

8. National Vaccine Advisory Committee. Strategies to achieve the healthy people 2020 annual influenza vaccine coverage goal for health-care personnel: recommendations from the national vaccine advisory committee. Public Health Rep, 2013;128(1):7–25.

9. Ye Ch, Zhu W, Yu J, et al. Low coverage rate and awareness of influenza vaccine among older people in Shanghai, China: a cross-sectional study. Hum Vaccin Immunother, 2018;14(11):2715–2721.

10. Lefèvre H, Schrimpf C, Moro MR, et al. HPV vaccination rate in French adolescent girls: an example of vaccine distrust. Arch Dis Child, 2018;103(8):740–746.

11. Fan J, Cong S, Wang N, et al. Pneumococcal vaccination rate in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014-2015. Zhonghua Liu Xing Bing Xue Za Zhi, 2020;41(7):1028–1033.

12. WHO. Coronavirus disease 2019 (COVID-19) – Situation Report – 51. (available online on 12.05.2021). Available from: https:// www.who.int/docs/default-source/coronaviruse/situation-reports/ 20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.

13. Dehning J, Zierenberg J, Spitzner FP, et al. Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions. Science, 2020;369(6500):eabb9789.

14. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun, 2020;109:102433.

15. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis, 2020;34:101623.

16. Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg, 2020;76:71–76.

17. Liao J, Fan S, Chen J, et al. Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults. Innov, 2020;1(1):100001.

18. Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA, 2020;323(18):1824–1836.

19. Kotrlik JW, Higgins CH. Organizational research: Determining appropriate sample size in survey research appropriate sample size in survey research. Inf Technol Learn Perform J, 2001;19(1):43.

20. Draugalis JR, Plaza MC. Best practices for survey research reports revisited: implications of target population, probability sampling, and response rate. Am J Pharm Educ, 2009;73(8):142.

21. Charles M, Bradley K. Indulging our gendered selves? Sex segregation by field of study in 44 countries. Am J Sociol, 2009;114(4):924–976.

22. FitzSimons D, Hendrickx G, Vorsters A, et al. Hepatitis B vaccination: A completed schedule enough to control HBV lifelong?: Milan, Italy, 17–18 November 2011. Vaccine, 2013;31(4):584– 590.

23. Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev, 2006;28(1):112– 125.

24. Schönberger K, Riedel C, Rückinger S, et al. Determinants of long-term protection after hepatitis B vaccination in infancy: a meta-analysis. Pediatr Infect Dis J, 2013;32(4):307–313.

25. Van Damme P. Long-term protection after hepatitis B vaccine. J Infect Dis, 2016;214(1):1–3.

26. Kučera Z, Pelikan J, Šteflová A. Health literacy in Czech population results of the comparative representative research. Čas Lék Česk, 2016;155(5):233–241.

27. Nejezchlebova H, Kiewra D, Zakovska A, et al. Students’ attitudes to tick risks. Ann Agric Environ Med, 2016;23(3):437–441.

28. Grgic-Vitek M, Klavs I. Low coverage and predictors of vaccination uptake against tick-borne encephalitis in Slovenia. Eur J Public Health, 2012;22(2):182–186.

29. Merrill RM, Kelley TA, Cox E, et al. Factors and barriers influencing influenza vaccination among students at Brigham Young University. Med Sci Monit, 2010;16(2):PH29–PH34.

30. Ramsey M, Marczinski CA. College students’ perceptions of H1N1 flu risk and attitudes toward vaccination. Vaccine, 2011;29(44):7599–7601.

31. Benjamin SM, Bahr KO. Barriers associated with seasonal influenza vaccination among college students. Influenza Res Treat, 2016;1–5.

32. Ahorsu DK, Lin CY, Imani V, et al. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict, 2020.

33. Husky MM, Kovess-Masfety V, Swendsen JD. Stress and anxiety among university students in France during Covid-19 mandatory confinement. Compr Psychiatry, 2020;102:152191.

34. Martínez-Lorca M, Martínez-Lorca A, Criado-Álvarez JJ, et al. The fear of COVID-19 scale: Validation in spanish university students. Psychiatry Res, 2020;293:113350.

35. Reznik A, Gritsenko V, Konstantinov V, et al. COVID-19 fear in Eastern Europe: Validation of the Fear of COVID-19 Scale. Int J Ment Health Addict, 2020;1–6.

36. Fabianova K, Kyncl J, Vlckova I, et al. COVID-19 reinfections. Epidemiol Mikrobiol Imunol, 2021;70(1):62–67.

37. Bednarczyk RA, Chu SL, Sickler H, et al. Low uptake of influenza vaccine among university students: evaluating predictors beyond cost and safety concerns. Vaccine, 2015; 33(14):1659– 1663.

38. Hunt Ch, Arthur A. Student nurses’ reasons behind the decision to receive or decline influenza vaccine: a cross-sectional survey. Vaccine, 2012;30(40):5824–5829.

39. Cornally N, Deasy EA, McCarthey G, et al. Student nurses’ intention to get the influenza vaccine. Br J Nurs, 2013;22(21):1207– 1211.

40. Kassianos G, Kuchar E, Nitsch-Osuch A, et al. Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries. Vaccine, 2018;36(44):6546–6552.

41. Uzunlar Ö, Özyer Ş, Başer E, et al. A survey on human papillomavirus awareness and acceptance of vaccination among nursing students in a tertiary hospital in Ankara, Turkey. Vaccine, 2013;31(17):2191–2195.

42. Lee EJ, Park JS. Knowledge about cervical cancer, health beliefs and human papillomavirus vaccination rate in female university students. Asian Oncol Nurs, 2011;11(1):65–73.

43. Jiang R. Knowledge, attitudes and mental health of university students during the COVID-19 pandemic in China. Child Youth Serv Rev, 2020;119:105494.

44. Grüner S, Krüger F. The intention to be vaccinated against COVID-19: stated preferences before vaccines were available. Appl Econ Lett, 2020;1–5.

45. Barello S, Nania T, Dellafiore F, et al. ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol, 2020;35(8):781–783.

46. Al-Azzam N, Elsalem L, Gombedza F. A cross-sectional study to determine factors affecting dental and medical students’ preference for virtual learning during the COVID-19 outbreak. Heliyon, 2020;6(12):e05704.

47. Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health, 2020.

48. Grech V, Gauci C. Vaccine hesitancy in the University of Malta Faculties of Health Sciences, Dentistry and Medicine vis-a-vis influenza and novel COVID-19 vaccination. Early Hum Dev, 2020.

49. Orlowski EJ, Goldsmith DJ. Four months into the COVID-19 pandemic, Sweden’s prized herd immunity is nowhere in sight. J R Soc Med, 2020;113(8):292–298.

50. Habib H. Has Sweden’s controversial covid-19 strategy been successful? BMJ, 2020;369:m2376.

51. Dube E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines, 2015;14(1):99–117.

52. Godlee F. What should we do about vaccine hesitancy? BMJ, 2019;365:l4044.

53. Busse JW, Kulkarni AV, Campbell JB, et al. Attitudes toward vaccination: a survey of Canadian chiropractic students. CMAJ, 2002;166(12):1531–1534.

54. Cvjetkovic SJ, Jeremic VL, Tiosavljevic DV. Knowledge and attitudes toward vaccination: A survey of Serbian students. J Infect Public Health, 2017;10(5):649–656.